S
Sajjan Rajpoot
Researcher at Indian Institute of Technology Indore
Publications - 16
Citations - 335
Sajjan Rajpoot is an academic researcher from Indian Institute of Technology Indore. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 5, co-authored 7 publications receiving 107 citations.
Papers
More filters
Journal ArticleDOI
Tumor-derived exosomes in the regulation of macrophage polarization
Mirza S. Baig,Anjali Roy,Sajjan Rajpoot,Dongfang Liu,Rajkumar Savai,Sreeparna Banerjee,Manabu Kawada,Syed M. Faisal,Rohit Saluja,Uzma Saqib,Tomokazu Ohishi,Kishore K. Wary +11 more
TL;DR: Based on the vesicular cargo, the molecular constituents, the exosomes have the potential to change the fate of macrophage phenotypes, either M1, classically activated macrophages, or M2, alternatively activated macophages.
Journal ArticleDOI
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.
TL;DR: Design of a novel peptide that could inhibit SARS-CoV-2 spike protein interaction with ACE2, thereby blocking the cellular entry of the virus is designed and suggested that computationally developed inhibitory peptide may be developed as an anti-SARS- covirus disease agent.
Journal ArticleDOI
Dual targeting of 3CLpro and PLpro of SARS-CoV-2: A novel structure-based design approach to treat COVID-19.
TL;DR: This paper proposes the repurposing of the Food and Drug Administration-approved, purchasable, and naturally occurring drugs as a dual-inhibitor for the SARS-CoV-2 cysteine proteases—3Chemotrypsin-like protease or main protease (3CLpro or Mpro) and Papain-likerotease (PLpro)—that are responsible for processing the translated polyprotein chain from the viral RNA-yielding functional viral proteins
Journal ArticleDOI
TIRAP in the Mechanism of Inflammation
Sajjan Rajpoot,Kishore K. Wary,Rachel Ibbott,Dongfang Liu,Dongfang Liu,Uzma Saqib,Teresa L. M. Thurston,Mirza S. Baig +7 more
TL;DR: In this article, the authors discuss the importance of the TIR domain in TIRAP as a key interface involved in protein interactions which could hence serve as a therapeutic target to dampen the extent of acute and chronic inflammatory conditions.
Journal ArticleDOI
Repurposing Thioridazine (TDZ) as an anti-inflammatory agent.
Mirza S. Baig,Anjali Roy,Uzma Saqib,Sajjan Rajpoot,Mansi Srivastava,Adnan Naim,Dongfang Liu,Rohit Saluja,Syed M. Faisal,Qiuwei Pan,Kati Turkowski,G. N. Darwhekar,Rajkumar Savai,Rajkumar Savai +13 more
TL;DR: Thioridazinehydrochloride, a potent antipsychotic drug against Schizophrenia was selected and its efficiency in inhibiting IκBα protein degradation and subsequent NF-κB activation to inhibit inflammation was experimentally validated.